Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Financial statements and analysis
Period names from company filings, with term end dates and filing dates
Income Statement (USD) Term End Date Filing Date | 2025 Dec 31, 2025 Mar 26, 2026 | 2024 Dec 31, 2024 Mar 26, 2026 |
|---|
Total Revenue | - | - |
Cost of Revenue | - | - |
Gross Profit | - | - |
Gross Margin % | - | - |
Research & Development | 29.18M 46.0% | 19.98M |
General & Administrative | 12.27M 73.2% | 7.08M |
Selling & Marketing | - | - |
SG&A Expenses | - | - |
Other Operating Expenses | - | - |
Total Operating Expenses | 41.45M 53.2% | 27.06M |
Cost and Expenses | - | - |
Operating Income | -41.45M 53.2% | -27.06M |
Operating Margin % | - | - |
EBITDA | - | - |
EBITDA Margin % | - | - |
Interest Expense | - | - |
Interest Income | 3.11M 135.8% | 1.32M |
Other Income (Expense) | - | - |
Pre-Tax Income | -39.87M 36.7% | -29.16M |
Pre-Tax Margin % | - | - |
Tax Provision | 0.00 | 0.00 |
Net Income | -39.87M 36.7% | -29.16M |
Net Margin % | - | - |
Basic EPS | -17.98 10.2% | -16.31 |
Diluted EPS | -17.98 10.2% | -16.31 |
Basic Shares Outstanding | 2.22M 24.0% | 1.79M |
Diluted Shares Outstanding | 2.22M 24.0% | 1.79M |